Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists have discovered a possible way to fight cerebral malaria - by giving patients carbon monoxide (CO)

14.05.2007
Cerebral malaria (CM) is a severe form of malaria that affects the brain and is fatal in about 30-50% of the cases. But researchers in Portugal, in an article about to be published in Nature Medicine, report a gene – Hmox1 – that protects against the disease by releasing CO into the host blood stream counteracting CM inflammatory processes (CO is known to have anti-inflammatory properties) and inhibiting the development of the infection in the brain.

Maria M Mota, one of the leaders of the study believes that their results in mice will be relevant to treat human cerebral malaria and, supporting this idea, the protein produced by Hmox1 has already been reported in cerebral malaria patients. And with 300-500 millions of people infected every year, a vaccine that so far has eluded scientists and a disease that is rapidly becoming resistant to the medication available, new therapies are urgently needed.

Malaria is one of the most devastating diseases, only second in impact to tuberculosis, and causing 1 in 5 of all childhood deaths in Africa. Half a million infected cases, largely in developing countries, result in a million deaths a year. The disease is transmitted through the bite of female mosquitoes and is characterised by fever and a general poor condition that, if the patient is healthy, can be effectively treated. But a vaccine continues to elude scientists and the emergence of insectide-resistant mosquitoes and parasites resistant to the malaria drugs available has led to an increase of malaria cases in recent years. Considering that 40% of the world population lives in affected areas, this increase can have catastrophic health and economical consequences, especially in developing countries, but not only there. In fact, and probably due to climate change, malaria mosquitoes have already appeared in places as “remote” as New York.

In conclusion, new effective therapies need to be developed and one possibility is to target the components of the host that interact with the parasite. In fact, although counterintuitive, this approach - as long as it does not interfere with the body normal functions- has the advantage of not loose efficiency due to parasite adaptations, as it is the case with current therapies.

And it was with this possibility in mind that Ana Pamplona, Miguel P Soares, Maria M Mota and colleagues at the Institute of Molecular Medicine and Gulbenkian Institute in Lisbon, Portugal and the University of Debrecen in Hungary studied two different strains of mice, both capable of being infected with Plasmodium and develop malaria but only one capable of develop a cerebral malaria-like disease (called experimental cerebral malaria or ECM). Using this difference as basis for their study the researchers tried to understand what laid behind ECM protection.

And it was found that protection was associated to the activation of the gene Hmxo1, which produces an enzyme (enzymes are proteins capable of triggering chemical reactions in the body) called heme oxygenase-1 (HO-1). HO-1, like the name states, oxidizes heme, an iron-containing molecule that exists inside red blood cells helping the transport of oxygen in the blood.

In fact, during malaria infection a large numbers of red blood cells are destroyed after being infected (anaemia is one of the major problems of the disease) and the molecule heme is released in large quantities into the blood stream of the host becoming a serious problem since this molecule is extremely toxic. To protect themselves animals in this situation produce HO-1, which transform heme into iron, carbon monoxide (CO) that is not toxic when generated this way and another non-toxic molecule called biliverdin. And Pamplona and colleagues noticed that there was a direct correlation between HO-1/CO production and ECM protection in the two strains of mice.

To test this correlation, next, ECM protected mice were genetically manipulated to loose HO-1 and this resulted in loss of protection further supporting the link HO-1/CO - ECM protection. On the other hand, mice that normally developed ECM when induced to produce HO-1 were protected against the disease. Administration of CO had the same protective effect suggesting that HO-1 effect was mediated through this gas.

Further tests showed that HO-1/CO protective effect was connected with blood brain barrier (BBB) integrity.

BBB is a protective layer existent between the brain tissues and the blood vessels whose role is to restrict the passage of substances and cells from the blood to avoid harm to this organ. During brain infection this barrier is disrupted leading to invasion by molecules and cells that although there mostly to combat infection can, nevertheless, provoke damage to the tissues. BBB disruption and brain invasion by blood components are hallmarks of (E)CM (meaning both ECM and its human counterpart CM) and researchers discovered that HO-1/CO was not only able to prevent this BBB disruption (and the concomitant invasion) but also micro vascular damage and brain haemorrhage, two other major characteristics of (E)CM.

But what was the exact mechanism of CO protection? CO did not affect the parasite levels or the red blood cells destruction showing that its protective effect was done in some other way. When infected red blood cells are destroyed, haemoglobin (the molecule in the red blood cell that carries oxygen) is released and rapidly oxidised just to become very unstable and release the (toxic) heme groups mentioned before that will accumulate in the infected tissues. What Pamplona, Mota and colleagues found was that CO bound haemoglobin stopping its oxidation and avoiding in this way the formation of free heme.

The next step was to try and link heme accumulation to ECM and in fact it was discovered that heme was capable of disrupting the BBB permitting the entrance of inflammatory mediators capable of provoke (E)CM symptoms.

In conclusion, Pamplona and colleagues in Portugal show that HO-1 and CO can inhibit the development of cerebral malaria symptoms, such as BBB disruption, brain haemorrhage and micro vascular congestion by preventing the formation of free heme. Their work describes a new “protective” gene against malaria suggesting that others might exist in humans and opening the door to a range of new therapies that have the added bonus of not be easily affected by the malaria parasite extraordinary capacity to adapt.

The research also shows that, if human experiments confirm Pamplona Soares, Mota and colleagues’ results, malaria patients might be cheaply and easily treated against CM development with small quantities of inhaled CO what would be a major step in the control of the disease and its fatalities.

Catarina Amorim | alfa
Further information:
http://www.nature.com/nm/index.html

Further reports about: BBB ECM HO-1 HO-1/CO Malaria Mota Pamplona cerebral cerebral malaria parasite protective

More articles from Life Sciences:

nachricht Modern genetic sequencing tools give clearer picture of how corals are related
17.08.2017 | University of Washington

nachricht The irresistible fragrance of dying vinegar flies
16.08.2017 | Max-Planck-Institut für chemische Ökologie

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Gold shines through properties of nano biosensors

17.08.2017 | Physics and Astronomy

Greenland ice flow likely to speed up: New data assert glaciers move over sediment, which gets more slippery as it gets wetter

17.08.2017 | Earth Sciences

Mars 2020 mission to use smart methods to seek signs of past life

17.08.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>